14 research outputs found
HPV vaccination in Africa in the COVID-19 era: a cross-sectional survey of healthcare providersâ knowledge, training, and recommendation practices
IntroductionAlthough the burden of cervical cancer in Africa is highest, HPV vaccination coverage remains alarmingly low in this region. Providersâ knowledge and recommendation are key drivers of HPV vaccination uptake. Yet, evidence about providersâ knowledge and recommendation practices about the HPV vaccine against a backdrop of emerging vaccine hesitancy fueled by the COVID-19 pandemic is lacking in Africa.MethodsA cross-sectional study was conducted in 2021â2022 among healthcare providers involved in cervical cancer prevention activities in Africa. They were invited to report prior training, the availability of the HPV vaccine in their practice, whether they recommended the HPV vaccine, and, if not, the reasons for not recommending it. Their knowledge about the HPV vaccine was assessed through self-reporting (perceived knowledge) and with three pre-tested knowledge questions (measured knowledge).ResultsOf the 153 providers from 23 African countries who responded to the survey (mean age: 38.5âyears, SD: 10.1), 75 (54.0%) were female and 97 (63.4%) were based In countries with national HPV immunization programs. Overall, 57 (43.8%) reported having received prior training on HPV vaccine education/counseling, and 40 (37.4%) indicated that the HPV vaccine was available at the facility where they work. Most respondents (109, 83.2%) reported recommending the HPV vaccine in their practice. Vaccine unavailability (57.1%), lack of effective communication tools and informational material (28.6%), and need for adequate training (28.6%) were the most commonly reported reasons for not recommending the HPV vaccine. While 63 providers (52.9%) reported that their knowledge about HPV vaccination was adequate for their practice, only 9.9% responded correctly to the 3 knowledge questions.ConclusionTo increase HPV vaccination coverage and counter misinformation about this vaccine in Africa, adequate training of providers and culturally appropriate educational materials are needed to improve their knowledge of the HPV vaccine and to facilitate effective communication with their patients and the community
Medical schools in sub-Saharan Africa
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/85361/1/MedicalSchoolsinSubSaharaAfrica.pd
Training the Next Generation of African Pathologists
Quality patient care requires correct and timely evidence-based diagnoses. Pathology and laboratory medicine training varies significantly across the continent, but is inadequate to serve the needs of the population. This article summarizes the current state of pathology workforce and training in sub-Saharan Africa; discusses challenges to recruitment and retention; and outlines the necessary elements for training and sustaining a robust workforce in pathology and laboratory medicine. The authors provide several case studies of institutions around the continent that include expansion of existing programs, a de novo program, South-South collaborations, and skill building for the existing workforce
Changes in HIV-Related Cervical Cancer Over a Decade in Cote d'Ivoire
PURPOSE: Major improvements have occurred in access to invasive cervical cancer (ICC) screening in HIV-infected women over the past decade in sub-Saharan Africa. However, there is limited information on changes in the burden of HIV-related ICC at a population level. Our objective was to compare HIV-related ICC over a decade and document factors associated with HIV infection in women with ICC in CĂŽte d'Ivoire. METHODS: A repeated cross-sectional study was conducted in referral hospitals of Abidjan, CĂŽte d'Ivoire, through the 2009-2011 and 2018-2020 periods. Women diagnosed with ICC were systematically tested for HIV. Demographics, ICC risk factors, cancer stage (International Federation of Gynecology and Obstetrics), and HIV characteristics were collected through questionnaires. Characteristics of HIV-related ICC were compared between the periods, and factors associated with HIV in women diagnosed with ICC in 2018-2020 were documented through a multivariable logistic model. RESULTS: During the 2009-2011 and 2018-2020 periods, 147 and 297 women with ICC were diagnosed with estimated HIV prevalence of 24.5% and 21.9% (P = .53), respectively. In HIV-infected women, access to antiretroviral treatment increased from 2.8% to 73.8% (P < 10(-4)) and median CD4 cell count from 285 (IQR, 250-441) to 492 (IQR, 377-833) cells/mm(3) (P = .03). In women diagnosed with ICC during the 2018-2020 period, HIV infection was associated with a less advanced clinical stage (International Federation of Gynecology and Obstetrics I or II stage) (adjusted OR, 2.2 [95% CI, 1.1 to 4.4]) and with ICC diagnosis through a systematic screening (adjusted OR, 10.5 [95% CI, 2.5 to 45.5]). CONCLUSION: Despite a persistently high proportion of HIV-related ICC over time in CĂŽte d'Ivoire, HIV was associated with less advanced clinical stage at ICC diagnosis. Recent improvements in ICC screening services across HIV clinics might explain this association and support their implementation across non-HIV health facilities
The Spectrum of Cancers in West Africa: Associations with Human Immunodeficiency Virus
<div><h3>Background</h3><p>Cancer is a growing co-morbidity among HIV-infected patients worldwide. With the scale-up of antiretroviral therapy (ART) in developing countries, cancer will contribute more and more to the HIV/AIDS disease burden. Our objective was to estimate the association between HIV infection and selected types of cancers among patients hospitalized for diagnosis or treatment of cancer in West Africa.</p> <h3>Methods</h3><p>A case-referent study was conducted in referral hospitals in CĂŽte dâIvoire and Benin. Each participating clinical ward enrolled all adult patients seeking care for a confirmed diagnosis of cancer and clinicians systematically proposed an HIV test. HIV prevalence was compared between AIDS-defining cancers and a subset of selected non-AIDS defining cancers to a referent group of non-AIDS defining cancers not reported in the literature to be positively or inversely associated with HIV. An unconditional logistic model was used to estimate odds ratios (OR) and their 95% confidence intervals (CI) of the risk of being HIV-infected for selected cancers sites compared to a referent group of other cancers.</p> <h3>Results</h3><p>The HIV overall prevalence was 12.3% (CI 10.3â14.4) among the 1,017 cancer cases included. A total of 442 patients constituted the referent group with an HIV prevalence of 4.7% (CI 2.8â6.7). In multivariate analysis, Kaposi sarcoma (OR 62.2 [CI 22.1â175.5]), non-Hodgkin lymphoma (4.0 [CI 2.0â8.0]), cervical cancer (OR 7.9 [CI 3.8â16.7]), anogenital cancer (OR 11.6 [CI 2.9â46.3]) and liver cancer (OR 2.7 [CI 1.1â7.7]) were all associated with HIV infection.</p> <h3>Conclusions</h3><p>In a time of expanding access to ART, AIDS-defining cancers remain highly associated with HIV infection. This is to our knowledge, the first study reporting a significant association between HIV infection and liver cancer in sub-Saharan Africa.</p> </div
Chronic viral hepatitis, HIV infection and Non-Hodgkin Lymphomas in West Africa, a case-control study
Non-Hodgkin Lymphomas (NHL) are underestimated causes of cancer in West Africa where chronic viral hepatitis and HIV are endemic. While the association with HIV infection has already been characterized, limited information is available on the association between chronic viral hepatitis and NHL in sub-Saharan Africa A case-control study was conducted in referral hospitals of Abidjan (Cote d'Ivoire) and Dakar (Senegal). Cases of NHL were matched with controls on age, gender and participating site. The diagnosis of NHL relied on local pathological examination completed with immunohistochemistry. HIV, HBV and HCV serology tests were systematically performed. A conditional logistic regression model estimated the associations by the Odds Ratio (OR) with their 95% confidence interval (CI). A total of 117 NHL cases (Abidjan n=97, Dakar n=20) and their 234 matched controls were enrolled. Cases were predominantly men (68.4%) and had a median age of 50âyears (IQR 37 - 57). While Diffuse Large B-cell lymphoma were the most reported morphological type (n=35) among mature B-cell NHL, the proportion mature T-cell NHL (30%) was high. The prevalence figures of HBV, HCV and HIV infection were 12.8%, 7.7% and 14.5%, respectively among cases of NHL. In multivariate analysis, HBV, HCV and HIV were independently associated with NHL with OR of 2.23 (CI 1.05-4.75), 4.82 (CI 1.52-15.29) and 3.32 (CI 1.54-7.16), respectively. Chronic viral hepatitis B and C were significantly associated with NHL in West Africa. Timely preventive measures against HBV infection and access to curative anti-HCV treatment might prevent a significant number of NHL
Distribution of ART use in HIV-positive patients according to the different AIDS and non-AIDS defining cancers
<p><b>in CĂŽte dâIvoire and Benin, the IeDEA West Africa Collaboration, 2009â2011.</b> *Patients not known to be HIV-positive prior t the study conduction â Patients with a previously documented HIV infection.</p
Medical schools in sub-Saharan Africa
Small numbers of graduates from few medical schools, and emigration of graduates to other countries, contribute to low physician presence in sub-Saharan Africa. The Sub-Saharan African Medical School Study examined the challenges, innovations, and emerging trends in medical education in the region. We identified 168 medical schools; of the 146 surveyed, 105 (72) responded. Findings from the study showed that countries are prioritising medical education scale-up as part of health-system strengthening, and we identified many innovations in premedical preparation, team-based education, and creative use of scarce research support. The study also drew attention to ubiquitous faculty shortages in basic and clinical sciences, weak physical infrastructure, and little use of external accreditation. Patterns recorded include the growth of private medical schools, community-based education, and international partnerships, and the benefit of research for faculty development. Ten recommendations provide guidance for efforts to strengthen medical education in sub-Saharan Africa. © 2011 Elsevier Ltd
Distribution of patients according to their cancer primary site and HIV status in CĂŽte dâIvoire and Benin (Nâ=â1,017), the IeDEA West Africa collaboration. 2009â2011.
<p>*Other than Kaposi sarcoma â Except melanoma â«Other locations including esophagus (nâ=â10), endocrine tumors (Nâ=â9), gallbladder & bile ducts (Nâ=â8) and other minor cancer types (nâ=â20).</p
Association between selected cancers and HIV infection in CĂŽte dâIvoire and Benin, the IeDEA West Africa collaboration, 2009â2011.
*<p>Adjusted on age taken as a continuous variable, gender (except for invasive cervical cancer) and lifetime number of sexual partners (<5 <i>versus</i> â„5).</p>**<p>n/N: number of HIV+ patients/number of patients with cancer.</p>â <p>Control group of cancers not known to be related with HIV infection from the existing literature: prostate, breast, colon/rectum, oesophagus, stomach, pancreas, endometrium, ovary, endocrine, sarcomas other than Kaposi sarcoma.</p>âĄ<p>See <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0048108#pone.0048108.s001" target="_blank">Table S1</a> for morphological types.</p><p>Abbreviations: OR Odd Ratio, CI Confidence Interval.</p